Compare iShares iBoxx $ Inv Grade Corporate Bond ETF (LQD) vs Orion Office REIT Inc (ONL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares iBoxx $ Inv Grade Corporate Bond ETF vs Orion Office REIT Inc — how do they compare? iShares iBoxx $ Inv Grade Corporate Bond ETF trades at $102.41 (market cap $28.50B), while Orion Office REIT Inc trades at $2.17 (market cap $125.50M). The key difference: iShares iBoxx $ Inv Grade Corporate Bond ETF is far larger — about 227.1× Orion Office REIT Inc's market cap, and Orion Office REIT Inc pays a 3.64% dividend while iShares iBoxx $ Inv Grade Corporate Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares iBoxx $ Inv Grade Corporate Bond ETF for 125 Days and Orion Office REIT Inc for 33 Days on average.
| LQD | ONL | |
|---|---|---|
Market Cap | $28.50B | $125.50M |
Volume | 37,320,110 | 303,276 |
Sector | Fixed Income | Real Estate |
52-Week High | $112.91 | $3.00 |
52-Week Low | $101.83 | $1.93 |
Typical Hold Time | 125 Days | 33 Days |
Enterprise Value | — | $542.43M |
Dividend Yield | — | 3.64% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LQD trades at $102.47 with a slight 0.34% daily gain amid a challenging bond market environment. The ETF shows bearish technical signals with moving averages indicating selling pressure, though oscillators remain neutral. Recent news highlights significant short interest growth of 53.1% in September and concerns about investment-grade corporate bonds as Treasury yields reach multi-decade highs.
The outlook remains cautious given the bearish technical setup and rising bond yields pressuring corporate debt valuations. Key risks include continued bond market volatility and higher borrowing costs for issuers. Investment opportunities exist for income-focused investors seeking 4.8% yield exposure to high-quality corporate bonds, though near-term pressure may persist.
Orion Office REIT (ONL) trades at $2.20, down 3.08% today, reflecting ongoing challenges in the office REIT sector. The stock shows a mixed technical picture with bearish moving averages but bullish oscillators. Fundamentally, the company faces significant headwinds with declining revenue from $208M in 2022 to $148M in 2025 and persistent net losses, though Q2 2026 showed a surprising EPS beat. Analyst sentiment is evenly split between Buy and Hold ratings.
ONL presents a high-risk opportunity with deep value characteristics. The stock trades at discounted valuation multiples (P/S 0.88, P/B 0.2) but faces substantial operational challenges including negative margins and declining revenue. The upcoming $0.02 dividend provides some income appeal, but investors must weigh the company's strategic repositioning efforts against ongoing office sector headwinds and financial losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About iShares iBoxx $ Inv Grade Corporate Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index is designed to provide a broad representation of the US dollar-denominated liquid investment-grade corporate bond market.
Read more on LQD →About Orion Office REIT Inc
Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Read more on ONL →
